Latest Insider Transactions at Alexion Pharmaceuticals, Inc. (ALXN)
This section provides a real-time view of insider transactions for Alexion Pharmaceuticals, Inc. (ALXN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALEXION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALEXION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2021
|
John J Orloff EVP, Research & Development |
SELL
Sale (or disposition) back to the issuer
|
Direct |
146,511
-100.0%
|
-
|
|
Jul 21
2021
|
Ludwig Hantson CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
580,809
-98.46%
|
-
|
|
Jul 21
2021
|
Andreas Rummelt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
28,109
-100.0%
|
-
|
|
Jul 21
2021
|
Francois Nader Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,921
-100.0%
|
-
|
|
Jul 21
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
116,075
-100.0%
|
-
|
|
Jul 21
2021
|
Daniel Bazarko SVP, Controller, CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
60,207
-100.0%
|
-
|
|
Jul 21
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
116,850
-100.0%
|
-
|
|
Jul 21
2021
|
Brian Goff EVP & Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
150,832
-100.0%
|
-
|
|
Jul 21
2021
|
David R Brennan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,873
-100.0%
|
-
|
|
Jul 21
2021
|
John T Mollen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,336
-100.0%
|
-
|
|
Jul 21
2021
|
Tanisha Carino EVP & CCAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
59,226
-100.0%
|
-
|
|
Jul 21
2021
|
Deborah Dunsire Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,629
-100.0%
|
-
|
|
Jul 21
2021
|
Judith A Reinsdorf Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,150
-100.0%
|
-
|
|
Jul 21
2021
|
Paul A Friedman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,840
-100.0%
|
-
|
|
Jul 21
2021
|
Aradhana Sarin EVP, CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
120,253
-100.0%
|
-
|
|
Jul 21
2021
|
Christopher J Coughlin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,347
-100.0%
|
-
|
|
Jul 14
2021
|
Brian Goff EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,144
+18.26%
|
-
|
|
Jul 14
2021
|
Tanisha Carino EVP & CCAO |
BUY
Grant, award, or other acquisition
|
Direct |
25,813
+30.35%
|
-
|
|
Jul 14
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,469
+21.13%
|
-
|
|
Jul 14
2021
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
60,144
+18.76%
|
-
|
|
Jul 14
2021
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
21,708
+16.64%
|
-
|
|
Jul 14
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,625
+20.55%
|
-
|
|
Jul 14
2021
|
Aradhana Sarin EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
56,313
+21.25%
|
-
|
|
Jul 14
2021
|
Ludwig Hantson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
240,741
+18.67%
|
-
|
|
Jun 08
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-1.44%
|
$164,256
$177.0 P/Share
|
|
Jun 08
2021
|
Brian Goff EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,086
-1.18%
|
$192,222
$177.0 P/Share
|
|
Jun 08
2021
|
John J Orloff EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,957
-2.22%
|
$346,389
$177.0 P/Share
|
|
May 20
2021
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,336
+7.66%
|
-
|
|
May 20
2021
|
Deborah Dunsire Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+7.87%
|
-
|
|
May 20
2021
|
John T Mollen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.0%
|
-
|
|
May 20
2021
|
Francois Nader Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.76%
|
-
|
|
May 20
2021
|
Judith A Reinsdorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.62%
|
-
|
|
May 20
2021
|
Andreas Rummelt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+4.25%
|
-
|
|
May 20
2021
|
Paul A Friedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+8.87%
|
-
|
|
May 20
2021
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,691
+3.1%
|
-
|
|
Mar 29
2021
|
Ludwig Hantson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,332
-0.66%
|
$359,128
$154.03 P/Share
|
|
Mar 01
2021
|
Tanisha Carino EVP & CCAO |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-2.12%
|
$109,022
$151.75 P/Share
|
|
Feb 28
2021
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
7,616
+16.52%
|
-
|
|
Feb 28
2021
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+21.7%
|
-
|
|
Feb 28
2021
|
Aradhana Sarin EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+27.68%
|
-
|
|
Feb 28
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,033
+21.88%
|
-
|
|
Feb 28
2021
|
Brian Goff EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,473
+21.05%
|
-
|
|
Feb 28
2021
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,321
+23.65%
|
-
|
|
Feb 28
2021
|
Tanisha Carino EVP & CCAO |
BUY
Grant, award, or other acquisition
|
Direct |
18,033
+34.57%
|
-
|
|
Feb 28
2021
|
Ludwig Hantson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,725
+19.24%
|
-
|
|
Dec 17
2020
|
Daniel Bazarko SVP, Controller, CAO |
SELL
Open market or private sale
|
Direct |
24,066
-16.82%
|
$3,778,362
$157.78 P/Share
|
|
Dec 17
2020
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,066
+19.8%
|
$2,839,788
$118.87 P/Share
|
|
Dec 16
2020
|
Ellen Chiniara EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,913
-16.7%
|
$3,126,341
$157.96 P/Share
|
|
Dec 16
2020
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,965
+37.63%
|
-
|
|
Dec 16
2020
|
Aradhana Sarin EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,363
-10.01%
|
$1,469,991
$157.96 P/Share
|